Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-29

Clinical Trial Update: Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating the combined effect of oxytocin and naltrexone on stress- and alcohol cue-induced craving in alcohol use disorder has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)
  • Oxytocin (Oxytocin)

Snippet

Sponsor: Central Institute of Mental Health, Mannheim | Conditions: Alcohol Use Disorder, Alcoholism | Phase 2, Phase 3 | Status: COMPLETED